Casdin Capital as of June 30, 2020
Portfolio Holdings for Casdin Capital
Casdin Capital holds 42 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invitae (NVTAQ) | 16.2 | $274M | 9.0M | 30.29 | |
| Blueprint Medicines (BPMC) | 7.2 | $121M | 1.6M | 78.00 | |
| Fate Therapeutics (FATE) | 6.2 | $105M | 3.1M | 34.31 | |
| Sarepta Therapeutics (SRPT) | 5.0 | $85M | 530k | 160.34 | |
| Myokardia | 5.0 | $84M | 870k | 96.62 | |
| Alnylam Pharmaceuticals (ALNY) | 4.8 | $82M | 550k | 148.11 | |
| Biolife Solutions Com New (BLFS) | 4.7 | $79M | 4.8M | 16.35 | |
| Bluebird Bio (BLUE) | 4.0 | $67M | 1.1M | 61.04 | |
| Agios Pharmaceuticals (AGIO) | 3.4 | $57M | 1.1M | 53.48 | |
| Codexis (CDXS) | 3.2 | $54M | 4.7M | 11.40 | |
| Burning Rock Biotech Sponsored Ads (BNR) | 2.8 | $47M | 1.7M | 27.01 | |
| Twist Bioscience Corp (TWST) | 2.7 | $45M | 1.0M | 45.30 | |
| Caredx (CDNA) | 2.5 | $42M | 1.2M | 35.43 | |
| Revolution Medicines (RVMD) | 2.5 | $42M | 1.3M | 31.57 | |
| Adverum Biotechnologies | 2.3 | $39M | 1.9M | 20.88 | |
| Adaptive Biotechnologies Cor (ADPT) | 2.0 | $35M | 713k | 48.38 | |
| Generation Bio (GBIO) | 2.0 | $34M | 1.6M | 21.00 | |
| Denali Therapeutics (DNLI) | 1.9 | $32M | 1.3M | 24.18 | |
| Constellation Pharmceticls I | 1.7 | $29M | 980k | 30.05 | |
| Beigene Sponsored Adr (BGNE) | 1.7 | $28M | 150k | 188.40 | |
| Allogene Therapeutics (ALLO) | 1.6 | $27M | 625k | 42.82 | |
| Fulcrum Therapeutics (FULC) | 1.6 | $26M | 1.4M | 18.29 | |
| Alector (ALEC) | 1.6 | $26M | 1.1M | 24.44 | |
| Magenta Therapeutics | 1.5 | $25M | 3.3M | 7.51 | |
| Amyris Com New (AMRSQ) | 1.4 | $23M | 5.3M | 4.27 | |
| Crispr Therapeutics Namen Akt (CRSP) | 1.2 | $20M | 266k | 73.49 | |
| Global Blood Therapeutics In | 1.1 | $19M | 300k | 63.13 | |
| Dermtech Ord ord (DMTK) | 1.1 | $19M | 1.4M | 13.23 | |
| Zai Lab Adr (ZLAB) | 0.9 | $16M | 190k | 82.13 | |
| Sangamo Biosciences (SGMO) | 0.8 | $13M | 1.5M | 8.96 | |
| Gritstone Oncology Ord (GRTS) | 0.7 | $12M | 1.9M | 6.64 | |
| Black Diamond Therapeutics (BDTX) | 0.7 | $12M | 289k | 42.16 | |
| Illumina (ILMN) | 0.7 | $11M | 30k | 370.37 | |
| Bristol-myers Squibb Right | 0.6 | $11M | 3.0M | 3.58 | |
| Orchard Therapeutics Ads | 0.6 | $9.9M | 1.7M | 6.00 | |
| Voyager Therapeutics (VYGR) | 0.6 | $9.5M | 750k | 12.62 | |
| Oric Pharmaceuticals (ORIC) | 0.5 | $8.5M | 252k | 33.73 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.3 | $5.7M | 135k | 42.56 | |
| Turning Point Therapeutics I | 0.3 | $4.8M | 75k | 64.59 | |
| Zymeworks | 0.3 | $4.7M | 130k | 36.07 | |
| Deciphera Pharmaceuticals (DCPH) | 0.2 | $3.9M | 65k | 59.72 | |
| Stoke Therapeutics (STOK) | 0.2 | $2.9M | 120k | 23.83 |
